The announcement comes swiftly after the drug ... Emcure, Eva Pharma, Ferozsons Laboratories Limited, Hetero, and Mylan (a subsidiary of Viatris) – will be able to produce and distribute generic ...

Generic drugs manufactured in India are linked to significantly more "severe adverse events" for patients who use them than ...

David Ricks said drugs like Mounjaro and Zepbound are priced to reflect the costs involved, patent expiry, and the enormous ...

The U.S. Food and Drug Administration approved Mirum Pharmaceuticals' genetic disorder drug on Friday, making it the first ...

Emcure Pharmaceuticals has opened its new formulation research and development (R&D) centre in Ahmedabad, in the Indian state of Gujarat. The centre will focus on developing complex drug delivery ...

In an interview with the state-backed People's Daily newspaper, the National Healthcare Security Administration (NHSA) said it performed evaluations to ensure that so-called generic drugs were ...

Public anger in China over concerns raised by doctors that generic drugs used in public hospitals are increasingly ineffective has led to a rare response from the government. Doctors say they ...

US President Donald Trump's executive order imposing a 10 percent tariff on Chinese imports is likely to drive up the cost of generic drugs in the US and exacerbate drug shortages, US media outlet ...

Despite increasing competition in the pharmaceutical industry, several generic drug companies are poised for growth. Though generic drugs represent more than 90% of dispensed prescriptions ...

Pune-based Emcure Pharmaceuticals Ltd inaugurated its “biggest” Formulation Research and Development Centre in Ahmedabad which is designed to enable breakthroughs in complex drug delivery systems.

Criticism over how the Chinese government buys drugs for its public health care system has ignited frustration over the quality of medicine. By Alexandra Stevenson and Zixu Wang Reporting from ...